Directional atherectomy with antirestenotic therapy vs drug-coated balloon angioplasty alone for isolated popliteal artery lesions

Journal of Endovascular Therapy

Volumn 24, Issue 2, 2017, Pages 181-188

  Stavroulakis, Konstantinos ^a,b   Schwindt, Arne ^a,b   Torsello, Giovanni ^a,b   Stachmann, Arne ^a,b   Hericks, Christiane ^a,b   Bosiers, Michel J ^a,b   Beropoulis, Efthymios ^a,b   Stahlhoff, Stefan ^a,b   Bisdas, Theodosios ^a,b  

^a UNIVERSITY OF MÜNSTER   (Germany)

^b ST FRANZISKUS HOSPITAL   (Germany)

Author keywords

angioplasty; atherectomy; complications; drug coated balloon; drug eluting balloon; occlusion; popliteal artery; reintervention; stenosis; stent

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; WARFARIN; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; BIOCOMPATIBLE COATED MATERIAL; CARDIOVASCULAR AGENT; PACLITAXEL;

AGED; ARTERIAL EMBOLIZATION; ARTERY LESION; ARTERY OCCLUSION; ARTICLE; BLOOD VESSEL CALCIFICATION; CARDIOVASCULAR CATHETER; CLAUDICATION; CLINICAL OUTCOME; COMPARATIVE STUDY; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; DIRECTIONAL ATHERECTOMY WITH ANTIRESTENOTIC THERAPY; DRUG COATED BALLOON ANGIOPLASTY; DUAL ANTIPLATELET THERAPY; EDEMA; EMBOLIC PROTECTION DEVICE; FALSE ANEURYSM; FEMALE; FOLLOW UP; HEART MUSCLE REVASCULARIZATION; HEMATOMA; HUMAN; INTERVENTIONAL CARDIOVASCULAR PROCEDURE; MAJOR CLINICAL STUDY; MALE; POPLITEAL ARTERY; PRIORITY JOURNAL; RESTENOSIS; STENT; ANEURYSM; ANGIOGRAPHY; ATHERECTOMY; DEVICES; DIAGNOSTIC IMAGING; EQUIPMENT DESIGN; GERMANY; MIDDLE AGED; PATHOPHYSIOLOGY; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PROCEDURES; RISK FACTOR; STENOSIS, OCCLUSION AND OBSTRUCTION; TIME FACTOR; TREATMENT OUTCOME; VASCULAR ACCESS DEVICE; VASCULAR PATENCY; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ANEURYSM; ANGIOGRAPHY; ANGIOPLASTY, BALLOON; ANTICOAGULANTS; ATHERECTOMY; CARDIOVASCULAR AGENTS; COATED MATERIALS, BIOCOMPATIBLE; CONSTRICTION, PATHOLOGIC; EQUIPMENT DESIGN; FEMALE; GERMANY; HUMANS; MALE; MIDDLE AGED; PACLITAXEL; PERIPHERAL ARTERIAL DISEASE; PLATELET AGGREGATION INHIBITORS; POPLITEAL ARTERY; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME; VASCULAR ACCESS DEVICES; VASCULAR PATENCY;

EID: 85018344618     PISSN: 15266028     EISSN: 15451550     Source Type: Journal    
DOI: 10.1177/1526602816683933     Document Type: Article

References (30)

1. Garcia L, Jaff MR, Metzger C, et al. Wire-interwoven nitinol stent outcome in the superficial femoral and proximal popliteal arteries: Twelve-month results of the SUPERB trial. Circ Cardiovasc Interv. 2015;8(5). doi:10.1161/CIRCINTERVENTIONS.113.000937.
2. León LR Jr, Dieter RS, Gadd CL, et al. Preliminary results of the initial United States experience with the Supera woven nitinol stent in the popliteal artery. J Vasc Surg. 2013;57:1014- 1022.
3. Scheinert D, Werner M, Scheinert S, et al. Treatment of complex atherosclerotic popliteal artery disease with a new self-expanding interwoven nitinol stent: 12-month results of the Leipzig SUPERA popliteal artery stent registry. JACC Cardiovasc Interv. 2013;6:65-71.
4. Parthipun A, Diamantopoulos A, Kitrou P, et al. Use of a new hybrid heparin-bonded nitinol ring stent in the popliteal artery: Procedural and mid-term clinical and anatomical outcomes. Cardiovasc Intervent Radiol. 2015;38:846-854.
5. Katsanos K, Spiliopoulos S, Paraskevopoulos I, et al. Systematic review and meta-analysis of randomized controlled trials of paclitaxel-coated balloon angioplasty in the femoropopliteal arteries: Role of paclitaxel dose and bioavailability. J Endovasc Ther. 2016;23:356-370.
6. Cortese B, Granada JF, Scheller B, et al. Drug-coated balloon treatment for lower extremity vascular disease intervention: An international positioning document. Eur Heart J. 2016;37:1096-1103.
7. Stavroulakis K, Bisdas T, Torsello G, et al. Combined directional atherectomy and drug-eluting balloon angioplasty for isolated popliteal artery lesions in patients with peripheral artery disease. J Endovasc Ther. 2015;22:847-852.
8. Zeller T. 12 Month DEFINITIVE AR results. Paper presented at: VIVA 2014: Vascular Interventional Advances; November 4-7, 2014; Las Vegas, NV, USA.
9. Roberts D, Niazi K, Miller W, et al. Effective endovascular treatment of calcified femoropopliteal disease with directional atherectomy and distal embolic protection: Final results of the DEFINITIVE Ca++ trial. Catheter Cardiovasc Interv. 2014;84:236-244.
10. Ansari F, Pack LK, Brooks SS, et al. Design considerations for studies of the biomechanical environment of the femoropopliteal arteries. J Vasc Surg. 2013;58:804-813.
11. Sixt S, Cancino O, Treszl A, et al. Drug-coated balloon angioplasty after directional atherectomy improves outcome in restenotic femoropopliteal arteries. J Vasc Surg. 2013;58:682-686.
12. Cioppa A, Stabile E, Popusoi G, et al. Combined treatment of heavy calcified femoro-popliteal lesions using directional atherectomy and a paclitaxel coated balloon: One-year single centre clinical results. Cardiovasc Revasc Med. 2012;13:219-223.
13. Beschorner U, Zeller T. Combination of mechanical atherectomy and drug-eluting balloons for femoropopliteal in-stent restenosis. J Cardiovasc Surg (Torino). 2014;55:347-379.
14. Tepe G, Beschorner U, Ruether C, et al. Drug-eluting balloon therapy for femoropopliteal occlusive disease: Predictors of outcome with a special emphasis on calcium. J Endovasc Ther. 2015;22:727-733.
15. Laird JR, Schneider PA, Tepe G, et al. Durability of treatment effect using a drug-coated balloon for femoropopliteal lesions: 24-month results of IN.PACT SFA. J Am Coll Cardiol. 2015;66:2329-2338.
16. Tepe G. IN.PACT global drug-coated balloon for complete total occlusion. Paper presented at Charing Cross International Symposium; March 15, 2016; London, UK.
17. Tepe G, Zeller T, Schnorr B, et al. High-grade, non-flowlimiting dissections do not negatively impact long- term outcome after paclitaxel-coated balloon angioplasty: An additional analysis from the THUNDER study. J Endovasc Ther. 2013;20:792-800.
18. McKinsey JF, Zeller T, Rocha-Singh KJ, et al. Lower extremity revascularization using directional atherectomy 12-month prospective results of the DEFINITIVE LE study. JACC Cardiovasc Interv. 2014;7:923-933.
19. Diamantopoulos A, Gupta Y, Zayed H, et al. Paclitaxelcoated balloons and aneurysm formation in peripheral vessels. J Vasc Surg. 2015;62:1320-1322.
20. Kadakia MB, Epps KC, Julien ME, et al. Early aneurysm formation after everolimus-eluting stent implantation. Circ Cardiovasc Interv. 2014;7:266-267.
21. Ramaiah V, Gammon R, Kiesz S, et al. Midterm outcomes from the TALON Registry: Treating peripherals with SilverHawk: Outcomes collection. J Endovasc Ther. 2006;13:592-602.
22. Tarricone A, Ali Z, Rajamanickam A, et al. Histopathological evidence of adventitial or medial injury is a strong predictor of restenosis during directional atherectomy for peripheral artery disease. J Endovasc Ther. 2015;22:712-715.
23. Jahnke T, Mueller-Huelsbeck S, Charalambous N, et al. Prospective, randomized single-center trial to compare cryoplasty versus conventional angioplasty in the popliteal artery: Midterm results of the COLD study. J Vasc Interv Radiol. 2010;21:186-194.
24. Semaan E, Hamburg N, Nasr W, et al. Endovascular management of the popliteal artery: Comparison of atherectomy and angioplasty. Vasc Endovascular Surg. 2010;44:25-31.
25. Rastan A, Krankenberg H, Baumgartner I, et al. Stent placement vs. balloon angioplasty for popliteal artery treatment: Two-year results of a prospective, multicenter, randomized trial. J Endovasc Ther. 2015;22:22-27.
26. Goltz JP, Ritter CO, Kellersmann R, et al. Endovascular treatment of popliteal artery segments P1 and P2 in patients with critical limb ischemia: Initial experience using a helical nitinol stent with increased radial force. J Endovasc Ther. 2012;19:450-456.
27. Werner M, Paetzold A, Banning-Eichenseer U, et al. Treatment of complex atherosclerotic femoropopliteal artery disease with a self-expanding interwoven nitinol stent: Midterm results from the Leipzig SUPERA 500 registry. EuroIntervention. 2014;10:861-868.
28. Myint M, Schouten O, Bourke V, et al. A real-world experience with the supera interwoven nitinol stent in femoropopliteal arteries: Midterm patency results and failure analysis. J Endovasc Ther. 2016;23:433-441.
29. Conway AM, Qato K, Bottalico D, et al. Occluded superficial femoral and popliteal artery stents can have a negative impact on bypass target. J Endovasc Ther. 2015;22:868-873.
30. Stavroulakis K, Donas KP, Torsello G, et al. Genderrelated long-term outcome of primary femoropopliteal stent placement for peripheral artery disease. J Endovasc Ther. 2015;22:31-37.